Innovation Pharmaceuticals Inc. (IPIX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.1 Million | -6.28 Million | -9.49 Million | -4.15 Million | -6.33 Million | -13.27 Million |
| Net Income | -3.16 Million | -7.04 Million | -13.87 Million | -6.64 Million | -8.68 Million | -16.36 Million |
| Depreciation & Amortization | 373 Thousand | 382 Thousand | 378 Thousand | 373 Thousand | 371 Thousand | 413 Thousand |
| Deferred income taxes | - | - | - | 1.85 Million | 114 Thousand | 212 Thousand |
| Stock-based compensation | 207 Thousand | 583 Thousand | 183 Thousand | 427 Thousand | 1.07 Million | 1.88 Million |
| Change in working capital | 310 Thousand | -372 Thousand | -847 Thousand | -113 Thousand | -1.24 Million | -1.64 Million |
| Other non-cash items | 172 Thousand | 168 Thousand | 4.66 Million | -50 Thousand | 2.03 Million | 2.21 Million |
| Investing Cash Flow | -60 Thousand | -4.08 Million | -72 Thousand | -91 Thousand | -46 Thousand | -104 Thousand |
| Investments in PPE | -60 Thousand | -80 Thousand | -72 Thousand | -91 Thousand | -86 Thousand | -117 Thousand |
| Acquisitions | - | -4 Million | - | - | 40 Thousand | 13 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -60.00 | -4 Million | -72.00 | -91.00 | -46.00 | 13 Thousand |
| Financing Cash Flow | -123 Thousand | 3.97 Million | 13.74 Million | 9.68 Million | 4.53 Million | 11.66 Million |
| Debt repayment | -37 Thousand | -1.03 Million | -4.88 Million | -79 Thousand | -1.89 Million | - |
| Dividends payments | -86 Thousand | - | - | - | - | - |
| Common Stock Repurchased | - | - | -670 Thousand | -55 Thousand | -91 Thousand | -172 Thousand |
| Common Stock Issuance | - | 5 Million | 9.62 Million | 9.74 Million | 2.73 Million | 11.83 Million |
| Other Financing Activities | -37 Thousand | 3.97 Million | 14.41 Million | 9.74 Million | 8.41 Million | 11.83 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 418 Thousand | 4000.00 | 520 Thousand | -84 Thousand | -1.05 Million | -1.51 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -108 Thousand | -376 Thousand | -1.36 Million | -29 Thousand | -188 Thousand | -131 Thousand |
| Cash at beginning of period | 3.8 Million | 10.19 Million | 6.01 Million | 579 Thousand | 2.42 Million | 4.14 Million |
| Cash at end of period | 1.51 Million | 3.8 Million | 10.19 Million | 6.01 Million | 579 Thousand | 2.42 Million |
| Capital Expenditure | -60 Thousand | -80 Thousand | -72 Thousand | -91 Thousand | -86 Thousand | -117 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.28 Million | -6.38 Million | 4.17 Million | 5.43 Million | -1.84 Million | -1.71 Million |
| Free Cash Flow | -2.16 Million | -6.36 Million | -9.56 Million | -4.24 Million | -6.41 Million | -13.39 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -880 Thousand | -681 Thousand | -3.16 Million | -698 Thousand | -361 Thousand | -1.42 Million |
| Depreciation & Amortization | 94 Thousand | 93 Thousand | 373 Thousand | 93 Thousand | 94 Thousand | 93 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3000.00 | 4000.00 | 207 Thousand | 4000.00 | 21 Thousand | 178 Thousand |
| Change in working capital | 42 Thousand | 126 Thousand | 310 Thousand | 94 Thousand | -245 Thousand | 335 Thousand |
| Other non-cash items | 64 Thousand | 89 Thousand | 172 Thousand | 38 Thousand | 14 Thousand | 381 Thousand |
| Investing Cash Flow | -2000.00 | -12 Thousand | -60 Thousand | -17 Thousand | -27 Thousand | -4000.00 |
| Investments in PPE | -2000.00 | -12 Thousand | -60 Thousand | -17 Thousand | -27 Thousand | -4000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.00 | -12.00 | -60.00 | -17.00 | -27.00 | -4000.00 |
| Financing Cash Flow | 25 Thousand | -41 Thousand | -123 Thousand | 3000.00 | -41 Thousand | -44 Thousand |
| Debt repayment | -25 Thousand | -25 Thousand | -37 Thousand | -3000.00 | -9000.00 | -6000.00 |
| Dividends payments | - | -16 Thousand | -86 Thousand | - | -32 Thousand | -38 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 25 Thousand | -25 Thousand | -37 Thousand | 6000.00 | -9000.00 | -6000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 36 Thousand | 286 Thousand | 418 Thousand | 3000.00 | -221 Thousand | 350 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6000.00 | -160 Thousand | -108 Thousand | 91 Thousand | -24 Thousand | -15 Thousand |
| Cash at beginning of period | 1.51 Million | 1.94 Million | 3.8 Million | 2.42 Million | 2.96 Million | 3.8 Million |
| Cash at end of period | 864 Thousand | 1.51 Million | 1.51 Million | 1.94 Million | 2.42 Million | 2.96 Million |
| Capital Expenditure | -2000.00 | -12 Thousand | -60 Thousand | -17 Thousand | -27 Thousand | -4000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -654 Thousand | -422 Thousand | -2.28 Million | -483 Thousand | -545 Thousand | -839 Thousand |
| Free Cash Flow | -679 Thousand | -381 Thousand | -2.16 Million | -486 Thousand | -504 Thousand | -795 Thousand |
G
ADJ
CTCGF
5945
VRDR
AMEN